RAMETTA, RAFFAELA
 Distribuzione geografica
Continente #
EU - Europa 6.521
NA - Nord America 5.201
AS - Asia 4.641
SA - Sud America 466
AF - Africa 83
OC - Oceania 34
Continente sconosciuto - Info sul continente non disponibili 7
AN - Antartide 1
Totale 16.954
Nazione #
US - Stati Uniti d'America 4.999
GB - Regno Unito 2.722
CN - Cina 1.689
SG - Singapore 1.278
IT - Italia 946
DE - Germania 861
SE - Svezia 485
RU - Federazione Russa 432
BR - Brasile 365
HK - Hong Kong 359
FR - Francia 272
VN - Vietnam 250
IN - India 211
BD - Bangladesh 158
FI - Finlandia 147
TR - Turchia 146
JP - Giappone 145
NL - Olanda 144
IE - Irlanda 142
CA - Canada 131
KR - Corea 100
UA - Ucraina 72
ID - Indonesia 59
PL - Polonia 45
MX - Messico 42
BE - Belgio 38
AR - Argentina 36
EU - Europa 36
GR - Grecia 36
TW - Taiwan 36
DK - Danimarca 35
AU - Australia 29
EG - Egitto 27
RO - Romania 27
CO - Colombia 25
IR - Iran 24
AT - Austria 22
PK - Pakistan 22
UZ - Uzbekistan 19
ES - Italia 18
IQ - Iraq 18
PH - Filippine 18
TH - Thailandia 17
HU - Ungheria 12
CL - Cile 10
CZ - Repubblica Ceca 10
SA - Arabia Saudita 10
CH - Svizzera 9
CI - Costa d'Avorio 9
VE - Venezuela 9
DZ - Algeria 8
NO - Norvegia 8
NP - Nepal 8
ZA - Sudafrica 8
AE - Emirati Arabi Uniti 7
IL - Israele 7
MY - Malesia 7
PR - Porto Rico 7
PT - Portogallo 7
CR - Costa Rica 6
LK - Sri Lanka 6
MN - Mongolia 6
PE - Perù 6
TN - Tunisia 6
AL - Albania 5
BH - Bahrain 5
BO - Bolivia 5
EC - Ecuador 5
JO - Giordania 5
NZ - Nuova Zelanda 5
OM - Oman 5
RS - Serbia 5
A2 - ???statistics.table.value.countryCode.A2??? 4
JM - Giamaica 4
MA - Marocco 4
PY - Paraguay 4
AZ - Azerbaigian 3
CM - Camerun 3
ET - Etiopia 3
GE - Georgia 3
HN - Honduras 3
HR - Croazia 3
KG - Kirghizistan 3
KH - Cambogia 3
LU - Lussemburgo 3
QA - Qatar 3
SK - Slovacchia (Repubblica Slovacca) 3
BY - Bielorussia 2
GD - Grenada 2
GT - Guatemala 2
KE - Kenya 2
KZ - Kazakistan 2
LT - Lituania 2
MD - Moldavia 2
MK - Macedonia 2
NG - Nigeria 2
PS - Palestinian Territory 2
SD - Sudan 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
Totale 16.964
Città #
Southend 2.572
Singapore 794
Ashburn 513
Milan 377
Chandler 363
Hong Kong 329
Beijing 314
San Jose 309
Dallas 261
Seattle 244
Hanover 243
Fairfield 221
Wilmington 191
Princeton 163
Council Bluffs 146
Cambridge 142
Dublin 137
Houston 132
Ann Arbor 127
Munich 124
New York 117
Dearborn 110
Los Angeles 102
Woodbridge 96
Santa Clara 94
Nanjing 91
Mountain View 78
Hangzhou 76
Lauterbourg 71
Toronto 70
Frankfurt am Main 68
Guangzhou 66
Helsinki 66
Redwood City 66
Tokyo 66
Ho Chi Minh City 63
Shanghai 63
Moscow 59
The Dalles 58
Buffalo 53
Des Moines 52
Bengaluru 51
Hanoi 50
Redmond 50
Changsha 48
Sunnyvale 48
Boardman 47
São Paulo 45
Phoenix 42
Rome 42
Andover 41
Jakarta 41
Columbus 40
Tianjin 38
Warsaw 38
Jinan 33
Berlin 31
Shenyang 31
Wuhan 31
Eitensheim 28
Somerville 28
Sakarya 27
Taipei 25
Chengdu 23
Serra 22
Amsterdam 21
Chicago 21
Grafing 20
Saint Petersburg 20
Nanchang 18
Athens 17
Cangzhou 17
Bogotá 16
Brussels 16
Hefei 16
Jacksonville 16
Jiaxing 16
London 16
Odernheim 16
Quanzhou 16
Shenzhen 16
Turin 15
Hebei 14
Nuremberg 14
Rio de Janeiro 14
Ankara 13
Atlanta 13
Haiphong 13
Silver Spring 13
Taizhou 13
Belo Horizonte 12
Falls Church 12
Fuzhou 12
Hamburg 12
Istanbul 12
Kunming 12
Pisa 12
Seoul 12
Buenos Aires 11
Da Nang 11
Totale 10.705
Nome #
Statin use and nonalcoholic steatohepatitis in at risk individuals 683
The role of insulin resistance in nonalcoholic steatohepatitis and liver disease development : a potential therapeutic target? 600
Prevalence and Risk Factors of Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Without Steatohepatitis 537
PNPLA3 I148M Polymorphism, Clinical Presentation, and Survival in Patients with Hepatocellular Carcinoma 423
UN¿AUMENTATA ESPRESSIONE DEL SUBSTRATO DEL RECETTORE DELL¿INSULINA 2 (IRS-2) È ASSOCIATA ALLA STEATOEPATITE E AL DISMETABOLISMO LIPIDICO IN PAZIENTI AFFETTI DA OBESITÀ GRAVE. 419
Prognostic impact of diabetes and prediabetes on survival outcomes in patients with chronic heart failure: A post-hoc analysis of the GISSI-HF (Gruppo Italiano per lo Studio della Sopravvivenza nella Insufficienza Cardiaca-Heart Failure) trial 406
Adipocyte PHLPP2 inhibition prevents obesity-induced fatty liver 404
The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent 372
Adiponectin in nonalcoholic fatty liver disease : correlation with liver damage and PNPLA3 genotype 320
Liver transcriptomics highlights interleukin-32 as novel NAFLD-related cytokine and candidate biomarker 309
Serum ferritin levels are associated with vascular damage in patients with nonalcoholic fatty liver disease 308
The rs2294918 E434K variant modulates PNPLA3 expression and liver damage 303
High fat diet subverts hepatocellular iron uptake determining dysmetabolic iron overload 302
PCSK7 gene variation bridges atherogenic dyslipidemia with hepatic inflammation in NAFLD patients 293
The i148m Pnpla3 polymorphism influences serum adiponectin in patients with fatty liver and healthy controls 282
Adiponectin in nonalcoholic fatty liver disease : correlation with liver damage and PNPLA3 genotype 277
The A736V TMPRSS6 Polymorphism Influences Hepatic Iron Overload in Nonalcoholic Fatty Liver Disease 276
Serum hepcidin and macrophage iron correlate with MCP-1 release and vascular damage in patients with metabolic syndrome alterations 272
Adiponectin in nonalcoholic fatty liver disease : correlation with liver damage and PNPLA3 genotype 272
Homozygosity for the PNPLA3/Adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease 270
Iron overload impairs the migratory ability of a model of immature and migratory GnRH neurons 269
The A736V TMPRSS6 polymorphism influences hepcidin and iron metabolism in chronic hemodialysis patients : TMPRSS6 and hepcidin in hemodialysis 267
Hepatic notch signaling correlates with insulin resistance and nonalcoholic fatty liver disease 265
Liver fat accumulation is associated with circulating PCSK9 levels 265
PNPLA3 I148M polymorphism, etiology, and clinical features of hepatocellular carcinoma 250
Protein phosphatase 1 regulatory subunit 3B gene variation protects against hepatic fat accumulation and fibrosis in individuals at high risk of nonalcoholic fatty liver disease 244
Patatin-like phospholipase domain containing-3 gene I148M polymorphism, steatosis, and liver damage in hereditary hemochromatosis 238
The APOC3 T-455C and C-482T promoter region polymorphisms are not associated with the severity of liver damage independently of PNPLA3 I148M genotype in patients with non-alcoholic fatty live 238
Dietary iron overload induces visceral adipose tissue insulin resistance 236
Increased circulating adiponectin in males with chronic HCV hepatitis 234
Beta-globin mutations are associated with parenchymal siderosis and fibrosis severity in patients with nonalcoholic fatty liver disease 231
Transmembrane 6 Superfamily Member 2 Gene Variant Disentangles Nonalcoholic Steatohepatitis From Cardiovascular Disease 225
Patatin-like phospholipase domain-containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C 221
Lack of association between peroxisome proliferator-activated receptors alpha and gamma2 polymorphisms and progressive liver damage in patients with non-alcoholic fatty liver disease: a case control study 219
Characterization and sub-cellular localization of SS1R, SS2R, and SS5R in human late-stage prostate cancer cells : effect of mono- and bi-specific somatostatin analogs on cell growth 218
Hepatic steatosis and PNPLA3 I148M variant are associated with serum Fetuin-A independently of insulin resistance 218
Impact of natural neuromedin-B receptor variants on iron metabolism 217
Hypermethylation of oncosuppressor genes in hereditary hemochromatosis 216
Insulin resistance promotes Lysyl Oxidase Like 2 induction and fibrosis accumulation in nonalcoholic fatty liver disease 216
Effect of the A736V TMPRSS6 polymorphism on the penetrance and clinical expression of hereditary hemochromatosis 213
Hepcidin resistance in dysmetabolic iron overload 209
IRON OVERLOAD IMPAIRS THE MIGRATORY PROPERTIES OF IMMATURE GNRH NEURONS IN VITRO 208
Genetic variants regulating insulin receptor signalling are associated with the severity of liver damage in patients with non-alcoholic fatty liver disease 204
Homozygosity for the PNPLA3/Adiponutrin I148m polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease 204
A tetra-primer amplification refractory mutation system polymerase chain reaction for the evaluation of rs12979860 IL28B genotype 203
A randomized trial of iron depletion in patients with nonalcoholic fatty liver disease and hyperferritinemia 201
NPLA3 I148M polymorphism, steatosis, liver damage, and treatment response in chronic hepatitis C 198
PNPLA3 I148M polymorphism, steatosis, liver damage, and treatment response in chronic hepatitis C 192
Increased insulin receptor substrate 2 expression is associated with steatohepatitis and altered lipid metabolism in obese subjects 189
A novel alpha1-antitrypsin null variant (PiQ0Milano) 183
LPIN1 rs13412852 polymorphism in pediatric nonalcoholic fatty liver disease 181
Beta-globin mutations are associated with parenchymal siderosis and fibrosis in patients with non-alcoholic fatty liver disease 179
Iron status modulates the expression of the ubiquitin ligase mdm-2 and of its target p53 in mouse hepatocytes and primary human monocytes 178
Paradoxical dissociation between hepatic fat content and de novo lipogenesis due to PNPLA3 sequence variant 178
The UCP2 -866 G>A promoter region polymorphism is associated with nonalcoholic steatohepatitis 176
Interaction between the PNPLA3 I148M mutation and body weight in determining steatosis and the progression to cirrhosis in hereditary hemochromatosis 171
MERTK rs4374383 polymorphism affects the severity of fibrosis in non-alcoholic fatty liver disease 169
Interaction between the PNPLA3 I148M mutation, body weight, and steatosis, in determining the progression to cirrhosis in hereditary hemochromatosis 168
The TM6SF2 E167K genetic variant induces lipid biosynthesis and reduces apolipoprotein B secretion in human hepatic 3D spheroids 167
PCSK9 rs11591147 R46L Loss‐of‐Function Variant Protects Against Liver Damage in Individuals with NAFLD 163
Beta-globin mutations are associated with parenchymal siderosis and fibrosis severity in patients with nonalcoholic fatty liver disease 159
PNPLA3 has retinyl-palmitate lipase activity in human hepatic stellate cells 159
Proprotein convertase 7 rs236918 associated with liver fibrosis in Italian patients with HFE-related hemochromatosis 155
Juvenile hemochromatosis associated with heterozygosity for novel hemojuvelin mutations and with unknown cofactors 148
Protective effect of TAT-delivered alpha-synuclein: relevance of the C-terminal domain and involvement of HSP70 148
Liver transplantation for hepatocellular carcinoma in a patient with a novel telomerase mutation and steatosis 146
Homozygosity for the patatin-like phospholipase-3/adiponutrin i148m polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease 146
Ceruloplasmin gene variants are associated with hyperferritinemia and increased liver iron in patients with NAFLD 145
From Environment to Genome and Back : a Lesson from HFE Mutations 143
GNPAT rs11558492 is not a major modifier of iron status : study of Italian hemochromatosis patients and blood donors 142
Iron-dependent regulation of MDM2 influences p53 activity and hepatic carcinogenesis 132
PNPLA3 I148M variant influences circulating retinol in adults with nonalcoholic fatty liver disease or obesity 122
Dysmetabolic hyperferritinemia and dysmetabolic iron overload syndrome (Dios): Two related conditions or different entities? 118
GNPAT p.D519G variant and iron metabolism during oral iron tolerance test 115
Totale 17.727
Categoria #
all - tutte 43.301
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.301


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021453 0 0 0 0 0 0 0 0 0 0 261 192
2021/20221.624 139 69 114 162 136 118 147 105 177 125 140 192
2022/20231.360 172 161 125 142 152 237 43 89 123 20 59 37
2023/2024932 28 90 72 68 206 88 49 46 31 57 84 113
2024/20252.100 81 208 53 220 193 72 136 204 94 186 209 444
2025/20264.303 499 254 522 270 435 309 458 286 497 317 456 0
Totale 17.727